Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 89
Filter
1.
Ann Epidemiol ; 62: 100-114, 2021 10.
Article in English | MEDLINE | ID: mdl-33065268

ABSTRACT

One of the ten greatest public health achievements is childhood vaccination because of its impact on controlling and eliminating vaccine-preventable diseases (VPDs). Evidence-based immunization policies and practices are responsible for this success and are supported by epidemiology that has generated scientific evidence for informing policy and practice. The purpose of this report is to highlight the role of epidemiology in the development of immunization policy and successful intervention in public health practice that has resulted in a measurable public health impact: the control and elimination of VPDs in the United States. Examples in which epidemiology informed immunization policy were collected from a literature review and consultation with experts who have been working in this field for the past 30 years. Epidemiologic examples (e.g., thimerosal-containing vaccines and the alleged association between the measles, mumps, and rubella (MMR) vaccine and autism) are presented to describe challenges that epidemiologists have addressed. Finally, we describe ongoing challenges to the nation's ability to sustain high vaccination coverage, particularly with concerns about vaccine safety and effectiveness, increasing use of religious and philosophical belief exemptions to vaccination, and vaccine hesitancy. Learning from past and current experiences may help epidemiologists anticipate and address current and future challenges to respond to emerging infectious diseases, such as COVID-19, with new vaccines and enhance the public health impact of immunization programs for years to come.


Subject(s)
COVID-19 , Measles-Mumps-Rubella Vaccine , Humans , Immunization , Immunization Programs , Policy , SARS-CoV-2 , United States/epidemiology , Vaccination
3.
Pediatrics ; 108(4): E60, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11581468

ABSTRACT

OBJECTIVE: To identify reservoirs of Haemophilus influenzae type b (Hib) pharyngeal carriage and assess barriers to vaccination among 2 Amish communities in Pennsylvania. METHODS: We investigated recent cases, performed community surveys for Hib vaccination coverage and pharyngeal carriage, and administered a questionnaire assessing vaccination knowledge and attitudes to 298 members of 2 Amish communities (A and B) in Pennsylvania and, as a comparison group, 136 non-Amish family members who participated in state immunization clinics. From December 1999 to February 2000, 8 cases of invasive Hib disease occurred among children who were 5 years of age or younger in Pennsylvania. Six of the case-patients were from Amish communities. None of the children had been vaccinated. RESULTS: Among children who were 5 years of age or younger, Hib vaccine coverage was low in the 2 Amish communities: A (9 [28%] of 32) and B (3 [7%] of 41) compared with the non-Amish group (19 [95%] of 20). Hib carriage prevalence was higher in both Amish communities than in the non-Amish group (A: 3%; B: 8%; non-Amish: 0%). More households in community B had 1 or more Hib carriers than in community A (8 [28%] of 29 vs 3 [9%] of 32). Among Amish parents who did not vaccinate their children, only 25% (13 of 51) identified either religious or philosophical objections as a factor; 51% (26 of 51) reported that vaccinating was not a priority compared with other activities of daily life. Seventy-three percent (36 of 49) would vaccinate their children if vaccination were offered locally. CONCLUSIONS: Undervaccinated communities in the United States still exist and allow circulation of Hib strains, resulting in disease among susceptible children. Identification of undervaccinated populations, such as the Amish, and targeted education and vaccination campaigns are essential to achieving elimination of Hib disease.


Subject(s)
Haemophilus Infections/epidemiology , Haemophilus Vaccines/therapeutic use , Haemophilus influenzae type b , Adolescent , Adult , Age Factors , Carrier State/epidemiology , Child , Child, Preschool , Ethnicity/psychology , Haemophilus Infections/prevention & control , Haemophilus influenzae type b/immunology , Haemophilus influenzae type b/isolation & purification , Health Knowledge, Attitudes, Practice , Health Surveys , Humans , Immunization/psychology , Immunization Programs/statistics & numerical data , Immunization Schedule , Infant , Parents/psychology , Pennsylvania/epidemiology , Pharynx/microbiology , Religion and Medicine , United States/epidemiology
7.
Health Educ Behav ; 27(6): 684-94, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11104368

ABSTRACT

The objective of this study was to describe Web sites with sex education material and assess the accessibility of specific information on the Internet. First, the authors conducted a review of Web sites using specific sex education keywords. Second, 27 undergraduate students were asked to locate information on proper condom use and sexually transmitted disease (STD) symptoms. The time, number of search attempts, and number of clicks needed to identify each piece of information were recorded. The authors identified 41 sites with sex education material from almost 6 million pages yielded by the keywords. Sixty-three percent of the 1,556 most compatible pages were categorized as pornography. The students found the information on condom use and STD symptoms in an average of 4 minutes, using fewer then six clicks and two searches. The authors concluded that general information on sex education is difficult to locate on the Internet and often lacks essential elements, but accurate and useful information on specific topics can be more easily obtained.


Subject(s)
Curriculum/standards , Information Services/standards , Information Storage and Retrieval/standards , Internet/standards , Sex Education/standards , Adolescent , Adult , Computer Literacy , Computer-Assisted Instruction/standards , Condoms , Erotica , Female , Humans , Male , Sexually Transmitted Diseases/diagnosis , Sexually Transmitted Diseases/prevention & control , Sexually Transmitted Diseases/therapy , Sexually Transmitted Diseases/transmission , Time Factors
9.
JAMA ; 284(17): 2189-90, 2000 Nov 01.
Article in English | MEDLINE | ID: mdl-11056588
11.
Ann Intern Med ; 133(3): 218-26, 2000 Aug 01.
Article in English | MEDLINE | ID: mdl-10906838

ABSTRACT

Injection drug users, their sex partners, and their children are at high risk for acquiring HIV infection and other bloodborne diseases. The risk for disease transmission in the United States is partly the result of restricted access to sterile injection equipment. Physicians and pharmacists can play an important role in providing syringe access by prescribing and dispensing syringes to patients who use injection drugs and cannot or will not enter drug treatment Prescribing and dispensing injection equipment are ethical, clinically appropriate, and fully consistent with current public health guidelines on disease prevention. An analysis of the laws of the 50 U.S. states, the District of Columbia, and Puerto Rico finds that physicians in nearly all these jurisdictions may legally prescribe sterile injection equipment to prevent disease transmission among drug-using patients and that pharmacists in most states have a clear or reasonable legal basis for filling the prescriptions. Given these medical and legal findings, physicians may wish to take a larger role in improving access to sterile injection equipment by prescribing this equipment for their patients where this practice is legal, and by joining efforts to change the law where it poses a barrier.


Subject(s)
HIV Infections/prevention & control , Pharmacists , Practice Patterns, Physicians' , Sterilization , Substance Abuse, Intravenous/virology , Syringes/standards , Drug Prescriptions , Ethics, Medical , HIV Infections/transmission , Health Policy , Humans , Malpractice , Needle Sharing/adverse effects , Risk Assessment , Substance Abuse, Intravenous/complications , United States , United States Dept. of Health and Human Services
13.
JAMA ; 284(2): 180, 2000 Jul 12.
Article in English | MEDLINE | ID: mdl-10889589
14.
Am Heart J ; 139(2 Pt 3): S86-95, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10650321

ABSTRACT

The Pediatric Cardiomyopathy Registry (PCMR) was established to describe the epidemiologic features and clinical course of selected cardiomyopathies in patients aged 18 years or younger and to promote the development of etiology-specific treatments. Sixty-one private and institutional pediatric cardiomyopathy practices in the United States and Canada were recruited to participate in the PCMR. The registry consists of a prospective, population-based cohort of patients in 2 regions (New England and the Central Southwestern United States) and a retrospective cohort of patients diagnosed between 1991 and 1996. Annual follow-up data are collected on all patients. As of June 1999, the PCMR consisted of 337 prospectively identified and 990 retrospectively identified patients. The PCMR has demonstrated the feasibility of establishing a large database of sociodemographic and clinical information on children with pediatric cardiomyopathy. Through this cooperative effort, the PCMR will obtain precise estimates of the incidence of pediatric cardiomyopathy and a better understanding of the natural history of this disease.


Subject(s)
Cardiomyopathies/epidemiology , Data Collection/methods , Pediatrics/statistics & numerical data , Registries , Research Design , Adolescent , Child , Feasibility Studies , Humans , Incidence , North America/epidemiology , Prospective Studies , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...